Indole-3-Propionic Acid Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease via AHR/AMPK Signaling Activation.

Authors

Yanting Huang, Meimei Yu, Jiaxin Lu, Chujun Lin, Shuhuan Li, Yalin Chen, Xin Chen, Hongliang Xue, Jing Chen, Lijie Su

Published in

Food science & nutrition. Volume 14. Issue 8. Pages e72206. Epub Aug 07, 2026.

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a health problem worthy of attention worldwide, characterized by excessive lipid accumulation in the liver. Previous studies have shown that indole-3-propionic acid (IPA) can ameliorate MAFLD; however, the regulatory mechanism by which IPA affects lipid synthesis requires further investigation. In vitro, FFA-induced HepG2 cells were treated with IPA (15-35 μM), and hepatic lipid accumulation was evaluated by Oil Red O staining. RNA-seq and Western blotting were employed to analyze AHR/AMPK signaling activation, and pharmacological inhibitors and agonists targeting AHR and AMPK were applied to explore the regulatory mechanism of IPA on lipid deposition. In vivo, C57BL/6J mice on a high-fat diet received 50 mg/kg IPA for 16 weeks, followed by histopathological evaluation and assessment of AHR/AMPK pathway activation. Results showed that IPA dose-dependently reduced lipid deposition in HepG2 cells. IPA inhibited lipid synthesis by activating AHR (inducing CYP1A1 expression and nuclear translocation) and promoting AMPK phosphorylation, thereby downregulating SREBP-1c and FAS expression. Pharmacological experiments demonstrated that IPA-induced AMPK activation was dependent on AHR nuclear translocation. Moreover, phosphorylated AMPK further promoted AHR nuclear translocation, indicating the existence of a potential bidirectional crosstalk between AHR and AMPK. In animal studies, IPA mitigated HFD-induced hepatic steatosis through activation of the AHR/AMPK signaling pathways. In conclusion, indole-3-propionic acid may alleviate MAFLD by ameliorating high-fat diet-induced hepatic lipid deposition through AHR/AMPK signaling activation.

PMID:
42569087
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.